Evolent Health, Inc. (EVH) |
| 2.53 0.2 (8.58%) 04-13 16:00 |
| Open: | 2.3 |
| High: | 2.56 |
| Low: | 2.2641 |
| Volume: | 1,098,790 |
| Market Cap: | 282(M) |
| PE Ratio: | -0.5 |
| Exchange: | New York Stock Exchange |
| Industry: | Medical - Healthcare Information Services |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 3.16 |
| Resistance 1: | 2.75 |
| Pivot price: | 2.35 |
| Support 1: | 2.10 |
| Support 2: | 1.74 |
| 52w High: | 12.065 |
| 52w Low: | 2.095 |
Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical platform for health plan administration and population health management. It offers financial and administrative management services, such as health plan services, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients, population health performance that delivers patient-centric cost-effective care. The Clinical Solutions segment offers specialty care management services support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation and specific market dynamics in oncology and cardiology; and holistic total cost of care improvement. The company was founded in 2011 and is headquartered in Arlington, Virginia.
| EPS | -5.070 |
| Book Value | 3.720 |
| PEG Ratio | 0.00 |
| Gross Profit | 3.582 |
| Profit Margin (%) | -28.49 |
| Operating Margin (%) | -2.06 |
| Return on Assets (ttm) | -0.1 |
| Return on Equity (ttm) | -66.5 |
Thu, 09 Apr 2026
Tudor Investment Corp Boosts Stake in Evolent Health - National Today
Wed, 08 Apr 2026
RBC Capital Lowers Price Target for Evolent Health (EVH) by 40% - GuruFocus
Wed, 08 Apr 2026
Evolent To Release First Quarter 2026 Financial Results on Thursday, May 7, 2026 - Sahm
Tue, 07 Apr 2026
Evolent Health (EVH): Buy, Sell, or Hold Post Q4 Earnings? - Yahoo Finance
Fri, 27 Mar 2026
Evolent Health (EVH) price target decreased by 32.38% to 6.01 - MSN
Thu, 26 Mar 2026
[SCHEDULE 13G/A] Evolent Health, Inc. Amended Passive Investment Disclosure - Stock Titan
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |